EN DE

Ningbo Tianyi Medical Appliance Co (301097) Fair Value & Analysis

Healthcare · CN · Market cap 2.9B CNY

NT Ningbo Tianyi Medical Appliance Co 301097 · SHE
Price¥34.70
Fair Value¥7.61
Upside-78.1%
Quality41/100
Watch Ningbo Tianyi Medical Appliance Co for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -1.8% net margin
Low debt · negative free cash flow
1.01% dividend yield
Mixed vs. peers (5/12)
Narrow moat 31/100
Evidence: Low Range ¥5.47 – ¥9.75 Share as image

Fair value as of: Jul 9, 2026

From 6 valuation models · updated 32 days ago

Share price +1.7% over the past month.

Below-average quality, and screening another 78% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥9.75). The favourable scenario is already priced in.
  • Weak quality (41/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (4 years)

¥47.50 ¥20.19 Fair Value ¥7.61 Apr 2022 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.

How to read this chart

52‑month range ¥20.19 – ¥47.50 · fair‑value band ¥5.47 – ¥9.75 · the ¥34.70 price screens above the ¥7.61 fair value. Dashed = 300-day average. As of Jul 9, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ningbo Tianyi Medical Appliance Co (301097) currently trades at ¥34.70, while our model-based Fair Value estimate is ¥7.61, implying the stock looks roughly 78.1% overvalued today. The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Over the trailing twelve months, Ningbo Tianyi Medical Appliance Co generated revenue of 641M CNY at a net margin of -1.8%. Revenue grew 66.3% year over year. It earns a return on equity of -1.0%. Net debt stands at 90.4M CNY. Fundamentals as of Jul 9, 2026

Our scenario range runs from ¥5.47 (bear case) to ¥9.75 (bull case); at ¥34.70, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 28% below its 52-week high and 32% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -43% fair-value upside, at -78%, 301097 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
ROIC Compounder ¥5.61 ¥6.28 ¥6.86 72
EPV ¥5.61 ¥6.28 ¥6.86 59
EV/EBITDA ¥14.91 ¥19.42 ¥23.94 54
All 6 models by family
Earnings-Based
EPV ¥5.61 ¥6.28 ¥6.86 59
Multiples
EV/EBIT ¥8.90 ¥11.42 ¥13.93 53
EV/EBITDA ¥14.91 ¥19.42 ¥23.94 54
EV/Revenue ¥6.74 ¥9.05 ¥11.36 43
Asset-Based
NCAV (Graham) ¥7.02 ¥9.41 ¥14.05 50
Economic Profit
ROIC Compounder ¥5.61 ¥6.28 ¥6.86 72

Widest divergence: Multiples (¥11.42) versus Earnings-Based (¥6.28). Highest evidence: ROIC Compounder (72).

Notify me when 301097 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 641M CNY
Revenue growth (YoY) +66.3%
Net margin -1.8%
Return on equity -1.0%
Free cash flow −210M CNY FY2025
Operating margin 18.6%
More key figures
EPS (TTM) ¥-0.1400
Dividend yield 1.0%
EPS growth (YoY) +90.9%
Net debt 90.4M CNY FY2025

Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 41/100

Of which business quality 41 · Market factors (momentum, volatility) 49

Profitability 12
Margins and returns on capital today
Quality Growth 63
Are margins and returns improving?
Cashflow 21
Earnings quality: real cash, not paper profit
Fin. Strength 69
Balance sheet, leverage, solvency risk
Investment 53
Disciplined investing over empire-building
Low Volatility 60
Calm price path (market factor)
Momentum 41
Price trend over the last 3–12 months (market factor)
52W Momentum 48
Distance to the 52-week high (market factor)
Net Issuance 42
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices to blood purification and ward nursing fields in China and internationally.

Full company description

Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices to blood purification and ward nursing fields in China and internationally. It offers hemodialysis tubing, artis piping kits, displacement and replacement fluid tubing, puncture device, dialyzer, hemodialysis concentrate and dry powder, and citric acid disinfectant; CRRT piping and series, plasma perfusion devices and separators, blood filters, waste liquid bags, side port connection tube and pipes, and dialysis replacement fluid bag puncture devices; feeders, feeding extension tubes and nutrient bags, and extended straws; and disposable oxygen tubing, cannula, blood transfusion and rectal air sets, endoscopic flushing tube, sterile syringe and needles, and micro adjustable infusion sets. The company was incorporated in 1998 and is headquartered in Ningbo, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Ningbo Tianyi Medical Appliance Co reported revenue of ¥576M in FY2025 versus ¥415M in FY2021, a compound +8.5%/yr. Reported net income was −¥16.2M in FY2025.

Growth Quality 26/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
576M CNY
Latest YoY
+37.4%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+13.0%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.7%
Avg. growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+10.5%
Revenue +8.5%/yr
FY21 ¥415M
FY22 ¥399M
FY23 ¥381M
FY24 ¥419M
FY25 ¥576M
Net income
FY21 ¥78.3M
FY22 ¥85.6M
FY23 ¥63.6M
FY24 −¥744K
FY25 −¥16.2M

301097 screens 78% overvalued. Compare with Intuitive Surgical, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Ningbo Tianyi Medical Appliance Co Fair Value". https://www.fairvalue-calculator.com/stock/301097

Peer Group

Medical Instruments & Supplies · 203 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 41 · Bottom 25%
Fair Value upside −78% · Bottom 25%
Return on assets 2% · Below median
Net margin (TTM) -2% · Bottom 25%
Operating margin (TTM) 19% · Above median
Revenue growth 66% · Top 25%
Dividend yield (TTM) 1.0% · Below median
Debt / equity 0.29× · Higher than median

Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper

P/B 0.38× · Cheaper than 75% of peers
P/S (TTM) 0.67× · Cheaper than 75% of peers
EV/EBITDA 2.6× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 100 · sector 27
PAST 0 · sector 25
HEALTH 86 · sector 96
DIVIDEND 20 · sector 32

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).

Stock Price Fair Value vs Fair Value
Intuitive Surgical, Inc ISRG $402.33 $150.04 -63%
EssilorLuxottica Société anonyme 1EL €172.45 €68.55 -60%
Medline Inc MDLN $41.11 $30.15 -27%
Becton, Dickinson and Company BDX $150.65 $103.53 -31%
Alcon Inc ALC $70.26 $39.78 -43%
ResMed Inc RMD $203.87 $187.89 -8%
West Pharmaceutical Services, Inc WST $353.71 $143.97 -59%
Straumann Holding STMN CHF 106.00 CHF 47.31 -55%
Sartorius Stedim Biotech S.A DIM €188.50 €51.16 -73%
Coloplast A/S COLOB kr 414.00 kr 382.22 -8%

Compare Ningbo Tianyi Medical Appliance Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Ningbo Tianyi Medical Appliance Co (301097) overvalued or undervalued?
As of Jul 9, 2026, our model estimates a fair value of ¥7.61 versus a price of ¥34.70, about −78% (overvalued).
What is the fair value of 301097?
Our model-based fair value for Ningbo Tianyi Medical Appliance Co is ¥7.61 (as of Jul 9, 2026), built from audited fundamentals. The current price is ¥34.70.
What is the quality score of 301097?
Ningbo Tianyi Medical Appliance Co has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Ningbo Tianyi Medical Appliance Co (301097)?
Ningbo Tianyi Medical Appliance Co reported trailing-twelve-month revenue of about 641M CNY (latest available figure, as of Jul 9, 2026).
What is the net profit margin of 301097?
The net profit margin of Ningbo Tianyi Medical Appliance Co is about -1.8%, meaning it is currently running at a net loss. Based on the latest reported figures.
Does Ningbo Tianyi Medical Appliance Co pay a dividend?
Ningbo Tianyi Medical Appliance Co currently shows a dividend yield of about 1.01% relative to its recent price (as of Jul 9, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Ningbo Tianyi Medical Appliance Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.